{
  "url": "https://openlegislation.uk/eu-directive-2012-52/annex/division-1/division-4",
  "json_url": "https://openlegislation.uk/eu-directive-2012-52/annex/division-1/division-4.json",
  "legislation": "eudr/2012/52",
  "legislation_title": "Commission Implementing Directive 2012/52/EU of 20 December 2012 laying down measures to facilitate the recognition of medical prescriptions issued in another Member State (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2012-52",
  "path": "annex/division/1/division/4",
  "kind": "division",
  "number": null,
  "heading": "Identification of the prescribed product, where applicable",
  "text": "‘Common name’ as defined by Article 1 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use\nThe brand name if:\n(a) the prescribed product is a biological medicinal product, as defined in point 3.2.1.1.(b) of Annex I (Part I) to Directive 2001/83; or\n(b) the prescribing health professional deems it medically necessary; in that case the prescription shall shortly state the reasons justifying the use of the brand name\nPharmaceutical formulation (tablet, solution, etc.)\nQuantity\nStrength, as defined in Article 1 of Directive 2001/83/EC\nDosage regimen",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2012/52/annex/division/1/division/4",
    "retrieved_at": "2026-11-01T15:21:55.142972+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}